Cancer is now the leading cause of death in Canada and infections are still a significant cause of death and suffering. It is becoming increasingly clear that infections cause many cancers with 20 per cent of cancers worldwide are caused by preventable or treatable infections such as H. pylori, the human papillomavirus (HPV) and hepatitis B.
Newly appointed Canada Research Chair (CRC) in Pharmacoepidemiology and Vaccine Evaulation, Salah Mahmud, an assistant professor in the department of community health sciences, will be using epidemiological methods to find ways to reduce the risk of developing and dying from these common cancers and infections by studying the use of widely used medications like aspirin, cholesterol lowering drugs and anti-depressants in preventing major cancers, such as prostate, colon and cervical. Mahmud will receive $500,000 over five years as a Tier2 chair holder.
Mahmud’s CRC appointment was announced today at the University of Manitoba by Minister of Public Safety Vic Toews, coinciding with the national announcement in Ottawa. Renewed support for four existing U of M Chairs was also announced. Chair holders are research leaders or rising stars in natural sciences and engineering, health sciences, or social sciences and humanities.
“Our government is committed to attracting and retaining the world’s best and brightest researchers, supporting innovation, creating jobs, and strengthening our economy,” said Minister of State Goodyear. “By investing in programs such as the Canada Research Chairs, we are fostering cutting-edge research and the generation of new innovations for the marketplace, for the benefit of Canadians.”
The new and renewed funding announced today is worth a combined $4.3 million.
“This welcome investment will spark innovation while enabling our exceptional researchers to focus on world-changing and life-saving discovery that benefits all of us,” said President and Vice-Chancellor David Barnard. “I want to thank the Government of Canada for the support provided here and at other research-intensive universities across the country.”
The four renewed Chairs are Diana Brydon, Warren Cariou, Michelle Driedger and Grant Hatch.
Diana Brydon (English, film and theatre), Canada Research Chair in Globalization and Cultural Studies draws from humanities and social sciences methods and perspectives to examine globalization and what it means for Canadian culture. Her research is providing important new insight into Canada’s social and cultural development and its place on the world stage. Brydon, a Tier 1 chair, will receive $1.4 million over the next seven years.
Warren Cariou (English, film and theatre), Canada Research Chair in Narrative, Community and Indigenous Cultures is exploring the ways narratives are used to create and sustain communities, particularly Aboriginal ones, within the larger context of the Canadian nation. Cariou will receive $500,000 in funding over the next five years as a Tier 2 chair.
Michelle Driedger (community health sciences), Canada Research Chair in Environment and Health Risk Communication has been involved in a program of research that examines how health risks are communicated in situations of uncertainty - when the experts do not have all of the answers - and yet policy decisions about health still has to be made. Driedger will receive $500,000 in funding over the next five years as a Tier 2 chair.
Grant Hatch (pharmacology and therapeutics/biochemistry and medical genetics, Manitoba Institute of Child Health), Canada Research Chair in Molecular Cardiolipin Metabolism is conducting research into cardiolipin metabolism that will potentially lead to new therapies for heart disease, diabetes, obesity, neurological disorders and Barth Syndrome (a rare genetic disorder in boys that causes a dangerously weakened heart muscle as well as a weakened immune system). Hatch will receive $1.4 million over the next seven years as a Tier 1 chair.
There are currently 45 CRCs at the University of Manitoba.
For more information contact Janine Harasymchuk, marketing communications office, Janine.Harasymchuk@ad.umanitoba.ca 204.474.7300 or cell 204.799.802